1. Anticancer Gold N-Heterocyclic Carbene Complexes: A Comparative in vitro and ex vivo Study.
- Author
-
Estrada-Ortiz N, Guarra F, de Graaf IAM, Marchetti L, de Jager MH, Groothuis GMM, Gabbiani C, and Casini A
- Subjects
- Animals, Antineoplastic Agents toxicity, Cell Line, Tumor, Heterocyclic Compounds toxicity, Humans, Kidney drug effects, Male, Methane analogs & derivatives, Methane chemistry, Methane pharmacology, Methane toxicity, Neoplasms drug therapy, Organogold Compounds toxicity, Rats, Wistar, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology, Heterocyclic Compounds chemistry, Heterocyclic Compounds pharmacology, Organogold Compounds chemistry, Organogold Compounds pharmacology
- Abstract
A series of organometallic Au
I N-heterocyclic carbene (NHC) complexes was synthesized and characterized for anticancer activity in four human cancer cell lines. The compounds' toxicity in healthy tissue was determined using precision-cut kidney slices (PCKS) as a tool to determine the potential selectivity of the gold complexes ex vivo. All evaluated compounds presented cytotoxic activity toward the cancer cells in the nano- or low micromolar range. The mixed AuI NHC complex, (tert-butylethynyl)-1,3-bis-(2,6-diisopropylphenyl)imidazol-2-ylidene gold(I), bearing an alkynyl moiety as ancillary ligand, showed high cytotoxicity in cancer cells in vitro, while being barely toxic in healthy rat kidney tissues. The obtained results open new perspectives toward the design of mixed NHC-alkynyl gold complexes for cancer therapy., (© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)- Published
- 2017
- Full Text
- View/download PDF